ATE453398T1 - Neuartige pharmakologische aktivitäten von curcuma longa extrakten - Google Patents

Neuartige pharmakologische aktivitäten von curcuma longa extrakten

Info

Publication number
ATE453398T1
ATE453398T1 AT00964281T AT00964281T ATE453398T1 AT E453398 T1 ATE453398 T1 AT E453398T1 AT 00964281 T AT00964281 T AT 00964281T AT 00964281 T AT00964281 T AT 00964281T AT E453398 T1 ATE453398 T1 AT E453398T1
Authority
AT
Austria
Prior art keywords
pharmacological activities
curcuma longa
novel pharmacological
longa extracts
extracts
Prior art date
Application number
AT00964281T
Other languages
English (en)
Inventor
Almagro Eliseo Quintanilla
Bosca Ana Ramirez
August Bernd
Zapata Jose Pardo
Alperi Joaquin Diaz
Mira David Pamies
Gutierrez Miguel Angel Carrion
Ortells Jose Miguel Sempere
Original Assignee
Asac Compania De Biotecnologia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asac Compania De Biotecnologia filed Critical Asac Compania De Biotecnologia
Application granted granted Critical
Publication of ATE453398T1 publication Critical patent/ATE453398T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00964281T 1999-09-23 2000-09-21 Neuartige pharmakologische aktivitäten von curcuma longa extrakten ATE453398T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902364A ES2154610B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos de curcuma longa.
PCT/ES2000/000354 WO2001021185A1 (es) 1999-09-23 2000-09-21 Nuevas actividades farmacologicas de los extractos de curcuma longa

Publications (1)

Publication Number Publication Date
ATE453398T1 true ATE453398T1 (de) 2010-01-15

Family

ID=8310389

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00964281T ATE453398T1 (de) 1999-09-23 2000-09-21 Neuartige pharmakologische aktivitäten von curcuma longa extrakten

Country Status (9)

Country Link
US (1) US6841177B1 (de)
EP (1) EP1133992B1 (de)
JP (1) JP2003509464A (de)
AT (1) ATE453398T1 (de)
AU (1) AU7525300A (de)
CA (1) CA2351482A1 (de)
DE (1) DE60043609D1 (de)
ES (3) ES2154610B1 (de)
WO (1) WO2001021185A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1221190C (zh) * 2001-02-09 2005-10-05 新纪元公司 解烟毒组合物和方法
US9265808B2 (en) 2004-03-23 2016-02-23 Lifeline Nutraceuticals Corporation Compositions for alleviating inflammation and oxidative stress in a mammal
CN1956726B (zh) 2004-03-23 2011-04-13 生命线营养健康公司 用于缓解哺乳动物炎症及氧化应激的组合物和方法
WO2008010697A1 (es) * 2006-07-19 2008-01-24 Herrera Ramirez Mario Alberto Fármaco a base de curcumina para el tratamiento de infección parasitaria provocada por la giardia lamblia
CN101686725A (zh) 2007-04-03 2010-03-31 刚迦·拉贾·高卡拉贾 消炎和抗氧化协同作用的膳食补充组合物
JP5486744B2 (ja) * 2007-10-03 2014-05-07 サベル コーポレーション ムユヨの花、トゲバンレイシの葉、及びウコンの根の抽出物を含む、肝炎を治療するための組成物
WO2009066303A2 (en) 2007-11-22 2009-05-28 Ganga Raju Gokaraju New synergistic phytochemical composition for the treatment of obesity
MX2010005441A (es) * 2007-12-21 2010-09-03 Asac Compania De Biotecologia Metodo para aumentar la eficacia terapeutica de los curcuminoides y analogos.
WO2009080842A1 (es) * 2007-12-21 2009-07-02 Asac Compañía De Biotecnología E Investigación Sa Composiciones fotoprotectoras
MY174568A (en) * 2013-12-31 2020-04-27 Sirim Berhad A bioactive composition having natural uv photoprotective properties
CN104888098A (zh) * 2015-05-04 2015-09-09 孙著叶 一种用于关节置换后静脉血栓的中药制剂及制备方法
JP7209691B2 (ja) * 2017-07-24 2023-01-20 サミ－サビンサ グループ リミテッド ウコン残渣物、その方法および組成物
CN107596252A (zh) * 2017-09-04 2018-01-19 中国科学院化学研究所 姜黄提取物及其制备方法、用途和保健品
JP6709001B1 (ja) * 2019-07-01 2020-06-10 ハウスウェルネスフーズ株式会社 ＴＮＦ−α又はＩＬ−６産生抑制用組成物
KR102327827B1 (ko) * 2019-11-01 2021-11-18 한국과학기술연구원 강황 추출물을 유효성분으로 포함하고 자외선 처리를 포함하는 건선 개선용 조성물
FR3104947B1 (fr) * 2019-12-18 2022-11-25 Fabre Pierre Dermo Cosmetique Extrait de Curcuma longa sans curcuminoïde, dans les dermatoses inflammatoires
CN111166847B (zh) * 2019-12-23 2021-12-31 成都锦华药业有限责任公司 一种含姜黄的药物组合物及其片剂和制备方法
RU2760551C1 (ru) * 2020-06-17 2021-11-29 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ лечения радиационных поражений организма и способ получения биологического препарата для лечения радиационных поражений организма
CN117771223A (zh) 2023-03-01 2024-03-29 孙良丹 化合物或其药用衍生物在抑制aim2蛋白活性中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4137540A1 (de) * 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
DE69531146T2 (de) * 1994-08-03 2004-06-03 A.S.A.C. Pharmaceutical International, A.I.E. Verfahren zur gewinnung von apolaren und polaren extrakten von kurkuma und ihre anwendungen
US5891924A (en) * 1996-09-26 1999-04-06 Research Development Foundation Curcumin (diferuloylmethane) inhibition of NFκB activation
US6019735A (en) * 1997-08-28 2000-02-01 Visco Technologies, Inc. Viscosity measuring apparatus and method of use
US20020164374A1 (en) * 1997-10-29 2002-11-07 John Jackson Polymeric systems for drug delivery and uses thereof

Also Published As

Publication number Publication date
EP1133992A1 (de) 2001-09-19
JP2003509464A (ja) 2003-03-11
WO2001021185A1 (es) 2001-03-29
US6841177B1 (en) 2005-01-11
ES2154610B1 (es) 2001-11-16
DE60043609D1 (de) 2010-02-11
ES2157862B1 (es) 2002-03-01
ES2154615B1 (es) 2001-11-16
ES2157862A1 (es) 2001-08-16
AU7525300A (en) 2001-04-24
ES2154615A1 (es) 2001-04-01
EP1133992B1 (de) 2009-12-30
ES2154610A1 (es) 2001-04-01
CA2351482A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
DE60043609D1 (de) Neuartige pharmakologische aktivitäten von curcuma longa extrakten
ATE229272T1 (de) Desinfizierende zusammensetzung auf basis von h2o2, säuren und metallionen
DK0733109T3 (da) BMP-12, BMP-13 og seneinducerende præparater dermed
DE69729646D1 (de) Formulierung zur verwendung in der vorbeugung von pathogen-induzierten erkrankungen, einschliesslich hiv und hsv
ES2105408T3 (es) Piridilmetilpiridonas sustituidas como antagonistas de angiotensina ii.
DE60133802D1 (de) Verwendung von säurestabilen proteasen in tierfutter
DE60004052D1 (de) Pharmazeutische zubereitungen auf der basis von levodopa, carbidopa und entacapone
ES2143059T3 (es) Complejos metalicos hidrofilos.
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
ATE383865T1 (de) Apolipoprotein a-i agonisten und deren verwendung zur behandlung dyslipidämischer erkrankungen
ATE328101T1 (de) Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften
DE69017874D1 (de) EPROM-Anordnung mit metallenen Source-Anschlüssen und ihre Herstellung.
DK0921812T3 (da) Insulinpræparater, som indeholder NaCi
ATE411802T1 (de) Kombinationspräparate von 1,4- benzothiepin-1,1- dioxidderivaten mit weiteren wirkstoffen und deren verwendung
IT1229195B (it) Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
DE69932510D1 (de) Vaskularisierungsinhibitoren
BR0115080A (pt) Derivados de acila e sulfonila de 2-(trans-1,4-diaminocicloexil)-purinas 6,9-dissubstituìdas e o uso destes como agentes antiproliferativos
EE04055B1 (et) Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks, ja nende kasutamine
FI931204A0 (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
AR039146A1 (es) Composiciones limpiadoras liquidas y empleo de las mismas
ATE189261T1 (de) Bifunktionelle urokinasevarianten mit verbesserten fibrinolytischen eigenschaften und thrombinhemmender wirkung
ATE416782T1 (de) Medizinische verwendung von il-174 agonisten und antagonisten
ES2175006T3 (es) N-(pirimidinil)-benzosulfonamidas como medicamentos.
TR199700435A2 (xx) Pestisit florolefin bile�imlerinin haz�rlanmas� i�in i�lem ve ara bile�imler.
EP1392294A4 (de) 7,8-kondensiertes 4$i(h)-chromen und analoga als caspase-aktivatoren und auslöser von apoptosis und ihre verewendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties